ifosfamide has been researched along with Hematologic Malignancies in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
" Major treatment-related adverse events were grade 3 or more hematologic toxicities, which included lymphopenia corresponding to dose-limiting toxicity." | 2.75 | Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study. ( Hosone, M; Isobe, Y; Katsuoka, Y; Komatsu, N; Oshimi, K; Shimizu, S; Sugimoto, K; Tsukune, Y; Yasuda, H, 2010) |
"Ifosfamide is an alkylating agent with a broad spectrum of activity in solid tumors and hematological malignancies." | 2.42 | Ifosfamide in hematological malignancies of adults. ( Elice, F; Rodeghiero, F, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sato, S | 1 |
Tanaka, E | 1 |
Tamai, Y | 1 |
Tsukune, Y | 1 |
Isobe, Y | 1 |
Yasuda, H | 1 |
Shimizu, S | 1 |
Katsuoka, Y | 1 |
Hosone, M | 1 |
Oshimi, K | 1 |
Komatsu, N | 1 |
Sugimoto, K | 1 |
Rodeghiero, F | 1 |
Elice, F | 1 |
Dazzi, C | 1 |
Cariello, A | 1 |
Rosti, G | 1 |
Monti, G | 1 |
Sebastiani, L | 1 |
Argnani, M | 1 |
Nicoletti, P | 1 |
Tienghi, A | 1 |
Leoni, M | 1 |
Fiorentini, G | 1 |
Turci, D | 1 |
Giovanis, P | 1 |
De Giorgi, U | 1 |
Marangolo, M | 1 |
1 review available for ifosfamide and Hematologic Malignancies
Article | Year |
---|---|
Ifosfamide in hematological malignancies of adults.
Topics: Adult; Antineoplastic Agents, Alkylating; Burkitt Lymphoma; Hematologic Neoplasms; Hodgkin Disease; | 2003 |
1 trial available for ifosfamide and Hematologic Malignancies
Article | Year |
---|---|
Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Female; Hematologic Neopl | 2010 |
2 other studies available for ifosfamide and Hematologic Malignancies
Article | Year |
---|---|
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells | 2019 |
Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combin | 1999 |